Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2014
08/21/2014US20140235574 Aripiprazole complex formulation and method
08/21/2014US20140235570 Therapeutic composition for the treatment of perianal disorders
08/21/2014US20140235559 Anti-cancer pharmaceutical composition
08/21/2014US20140235555 Pharmaceutical compositions comprising polyethylene glycol having a molecular weight of less than 600 daltons
08/21/2014US20140235530 Spray Drying Vancomycin
08/21/2014US20140235527 Composition for treatment or prevention of erectile dysfunction including dkk2 protein or dkk2 gene thereof and use of the composition
08/21/2014US20140234444 Method of using a film-shaped preparation comprising oily substances for oral administration
08/21/2014US20140234429 Super paramagnetic iron oxide nanoparticles with metallic coatings and a method of syhthesizing the same
08/21/2014US20140234424 Prame purification
08/21/2014US20140234422 Vaccine Composition With Aluminium Hydroxide Nanoparticles
08/21/2014US20140234421 Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
08/21/2014US20140234420 Method of Treating Skin Disorders using Nanoscale Delivery Devices and Transdermal Enhancing Compositions
08/21/2014US20140234419 Methods and compositions for wound healing
08/21/2014US20140234418 Method for treating intestinal fibrosis
08/21/2014US20140234417 Tablet comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1h-quinolin-2-one or a salt thereof
08/21/2014US20140234416 Use of ferric citrate in the treatment of chronic kidney disease patients
08/21/2014US20140234415 Tablet Dosage Forms
08/21/2014US20140234414 Novel Dosage Form
08/21/2014US20140234413 Caged platinum nanoclusters for anticancer chemotherapeutics
08/21/2014US20140234411 Seamless capsule and manufacturing method therefor
08/21/2014US20140234410 Combination products
08/21/2014US20140234409 Nicotinamide compositions and the therapeutic use thereof
08/21/2014US20140234406 NOVEL NANOPARTICULATE SUSPENSION FOR INCORPORATING FAT-SOLUBLE VITAMINS IN THE TREATMENT OF HAIR THINNING and HAIR LOSS
08/21/2014US20140234403 Liposome production using isopropanol
08/21/2014US20140234402 Intravenous Infusion of Curcumin and a Calcium Channel Blocker
08/21/2014US20140234400 Targeted Lipid-Drug Formulations for Delivery of Drugs to Myeloid and Lymphoid Immune Cells
08/21/2014US20140234397 Treatment of klebsiella pneumoniae with liposomally formulated glutathione
08/21/2014US20140234396 External patches containing etofenamate
08/21/2014US20140234395 Plaster having adjustable occlusion
08/21/2014US20140234394 Benefical contact surfaces for functional objects
08/21/2014US20140234393 Adhesive patch
08/21/2014US20140234392 Physically and chemically stable nicotine-containing particulate material
08/21/2014US20140234390 Sustained drug delivery implant
08/21/2014US20140234389 Sustained drug delivery implant
08/21/2014US20140234382 Peptide nanoparticles and uses therefor
08/21/2014US20140234380 Composition for management of periodontal disease
08/21/2014US20140234307 Method of treating multiple sclerosis by intrathecal depletion of b cells and biomarkers to select patients with progressive multiple sclerosis
08/21/2014US20140234276 Means and methods for liver regeneration
08/21/2014US20140234229 Pharmaceutical compositions
08/21/2014US20140234228 Effervescent compositions containing n-acetylcysteine
08/21/2014US20140234227 Foam formulations
08/21/2014US20140234225 Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer
08/21/2014US20140234212 Targeted Buccal Delivery of Agents
08/21/2014US20140234211 Supramolecular aggregates containing amphiphilic monomers, chelating agents and peptides for use for drug delivery and as contrast agents
08/21/2014US20140234210 Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
08/21/2014US20140230833 Nicotine delivery product and method for producing it
08/21/2014DE50103551C5 Neue tiotropium-haltige inhalationspulver New tiotropium-containing inhalation powder
08/21/2014DE112012003995T5 Caspofunginpräparat mit geringem Verunreinigungsgehalt, Verfahren zu seiner Herstellung und seine Verwendung Caspofunginpräparat with low impurity content, process for its preparation and its use
08/21/2014DE10066235C5 Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens Method and medicament for the inhibition of expression of a given gene
08/20/2014EP2767531A1 Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anti-cancer agent, method for producing and using same
08/20/2014EP2767293A1 Composition for the accelerated wound healing of damaged tissue
08/20/2014EP2767292A1 Sustained Local Anesthetic Composition Containing SAIB
08/20/2014EP2767289A1 Improved release of a beneficial substance from a bolus
08/20/2014EP2767285A1 Tablet including 7-[4-(4-benzo[beta]thiophen-4-yl-piperazin-1-yl) butoxy]-1h-quinolin-2-one or salt thereof
08/20/2014EP2767274A1 Carotenoid-containing composition and method for producing same
08/20/2014EP2767272A1 Solid pharmaceutical dosage form of dolutegravir
08/20/2014EP2767163A1 Transmucosal administration of drug compositions for treating and preventing disorders in animals
08/20/2014EP2766682A1 Process line for the production of freeze-dried particles
08/20/2014EP2766423A1 Injection-molded dosage form
08/20/2014EP2766051A1 Porphyrin-phospholipid conjugate microbubbles and their use as contrast agents.
08/20/2014EP2766006A1 Compositions comprising salbutamol sulphate
08/20/2014EP2766005A1 Compositions comprising salbutamol sulphate
08/20/2014EP2766001A1 Buffered oxygen therapeutic
08/20/2014EP2765999A1 Ingestible multi-sheet unit having predetermined functions and combinations
08/20/2014EP2765998A1 A gastroretentive dosage system and process of preparation thereof
08/20/2014EP2765997A2 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof
08/20/2014EP2765996A2 Nanoparticles for controlling bleeding and drug delivery
08/20/2014EP2765995A1 Dietary supplements with rapid buccal dissolution
08/20/2014EP2765994A1 Crystalline microparticles of a beta-agonist coated with a fatty acid
08/20/2014EP2765993A1 Formulations of cyclopropanecarboxylic acid {2-(1s)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1h-isoindol-4-yl}-amidecelgene corporation state of incorporation:delaware
08/20/2014EP2765992A1 Foam formulations
08/20/2014EP2765991A1 In situ forming hydrogel and method using same
08/20/2014EP2765990A2 Solid dispersion
08/20/2014EP2765989A1 Methods and compositions for rapid transbuccal delivery of active agents
08/20/2014EP2765988A1 Ocular composition containing bromfenac with increased bioavailability
08/20/2014EP2765987A1 Compositions for the treatment of dry eye
08/20/2014EP2765986A1 Prevention and treatment of ocular conditions
08/20/2014EP2765985A1 Orally dispersible tablet
08/20/2014EP2765981A1 Use of an oral composition including a mixture of a least one polyphenol, zinc, and vitamin c
08/20/2014EP2765866A1 Novel coating system
08/19/2014US8809615 Adhesive preparation
08/19/2014US8809495 Peptides imparting cell permeability to lipid membrane structure and/or enhancing cell permeability of lipid membrane structure, and lipid membrane structure comprising lipid bound to such peptide as constituent lipid and having cell permeability or showing enhanced cell permeability
08/19/2014US8809394 Tranexamic acid formulations
08/19/2014US8809375 Spot-on pesticide composition
08/19/2014US8809374 Spot-on pesticide composition
08/19/2014US8809272 Use of liposomal Wnt composition to enhance osseointegration
08/19/2014US8809271 Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
08/19/2014US8808771 Active ingredient delivery system with an amorphous metal salt as carrier
08/19/2014US8808764 Methods and compositions for increasing growth hormones
08/19/2014US8808763 Methods for improving sleep efficiency in healthy human beings
08/19/2014US8808757 Herbal ointment for musculoskeletal and joint-related conditions
08/19/2014US8808752 Controlled release particles and method for producing the same
08/19/2014US8808751 Methods for the preparation of biologically active compounds in nanoparticulate form
08/19/2014US8808750 Microporous zirconium silicate for the treatment of hyperkalemia
08/19/2014US8808749 Polymer conjugate of bioactive substance having hydroxy group
08/19/2014US8808748 Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same
08/19/2014US8808747 Nucleic acid microparticles for pulmonary delivery
08/19/2014US8808746 Sustained-release microspheres and methods of making and using same
08/19/2014US8808745 Morphine polymer release system
08/19/2014US8808744 Drug delivery system based on polyethylene vinylacetate copolymers
1 ... 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 ... 2991